Author - jbrown

Read the latest summaries from the ISN Journal portfolio

Kidney International®   Pegcetacoplan prophylaxis for recurrent C3 glomerulopathy with multifactorial genetic background  C3 glomerulopathy (C3G) has a high risk of recurrence after kidney transplantation, and there is limited evidence on how best to prevent it.  This case report describes a child with severe, early-onset C3G and a complex genetic background who received pegcetacoplan before and after a living-donor kidney transplant as prophylaxis...

Advance your renal pathology expertise in 2027: Apply for an ISN bursary 

Delegates review biopsy slides at the WCN’26 Renal Pathology Course in Japan   Applications are now open for the 2027 ISN Renal Pathology Bursaries, which support successful applicants in attending selected renal pathology events worldwide.  Explore the 2027 opportunities   Recipients will gain access to specialist training, connect with international experts and peers, and build knowledge and skills they can apply in their home institutions.  Apply for a bursary...

Building expertise in glomerular diseases and renal pathology for better patient care 

  Faculty and delegates at the ISN Primer Course in Glomerular Diseases in Montevideo, Uruguay  ISN members had the opportunity to strengthen their clinical and diagnostic expertise through two focused ISN Primer Courses* held in Montevideo, Uruguay, in August 2026.  The ISN Primer Course in Glomerular Diseases offered participants the chance to explore real-world approaches to managing glomerular diseases...

ISN global engagement in September: supporting kidney care education in Brazil, Australia, Italy, and South Africa  

This September, the ISN will contribute to nephrology events in Brazil, Australia, Italy, and South Africa, offering kidney care professionals opportunities to exchange knowledge, build connections, and share expertise.   33rd Brazilian Congress of Nephrology  September 16-19, 2026 Belo Horizonte, Brazil  This congress is an ISN Continuing Medical Education Program-supported meeting, enabling speakers Marina Papaginovic Leiva (Argentina) and Jorge Rico Fontalvo (Colombia) to...

Help lead the ISN forward: nominations open for 2027–29 leadership roles 

Who is ready to guide the ISN at both global and regional levels? Nominations are now open for the election of 2027–29 ISN leaders, including President-Elect; and, Regional Board Deputy Chairs, who also serve on the ISN Council, for all 10 ISN regions.  View details and submit your nomination  This is an opportunity for ISN members to help drive the society’s mission forward by...

Eight editions of kidney stories on camera: bringing lived experience into global focus 

Since its launch in 2019, the ISN Community Film Event is seen as a distinctive creative platform where patients, families, healthcare professionals, and advocates can highlight the impact of living with kidney diseases by sharing their personal experiences.  Submit your film  Across eight editions, the films have taken viewers into remote communities, through transplant journeys, and into dialysis units, hospitals, and homes, depicting uncertainty and challenges alongside resilience and hope.  With submissions now open for...

Fresh perspectives for the ISN YNC: Meet the new members 

The ISN values the perspectives and contributions of its younger members and supports them as they develop into the next generation of global kidney health leaders. The ISN Young Nephrologists Committee (ISN YNC) is a key part of this commitment, bringing together early-career professionals from around the world to contribute to ISN activities and develop their networks, skills, and leadership experience.  For 2026–28, eight new...

ISN and ISGD strengthen collaboration to advance global kidney care

The ISN and the International Society of Glomerular Disease (ISGD) have signed a Memorandum of Understanding to establish a long-term partnership toward advancing kidney health worldwide. Through the partnership, the two societies will work more closely together, share expertise, and identify opportunities for joint initiatives, strengthening complementarity between their respective activities.

ISN Journal summaries on belimumab in lupus nephritis and deceased donation in Tamil Nadu

Kidney International®   Insights from the BLISS-LN Phase 3 study of biomarker associations with kidney response to belimumab in lupus nephritis   Lupus nephritis is complex and difficult to treat, and clinicians need better tools to understand which patients are most likely to benefit from specific therapies.  Using data from the Phase 3 BLISS-LN study, researchers assessed how belimumab affected immune...

Be part of the global community moving kidney care forward 

ISN membership is more than a subscription; it's your place in the leading global kidney health community.   Whether you're early in your career or an established leader, the ISN connects you to people, resources and opportunities that challenge, inspire, and support you every step of the way.   Join the ISN or renew your membership for the rest of 2026 at 50% off with promo code 50ISN26  In addition to discounted ISN events, ISN membership gives you access to:  Kidney...

Capturing CKD complexity through cohort studies: iNET-CKD paper published in KIR 

Published in Kidney International Reports®, a new perspective paper from the ISN International Network of Chronic Kidney Disease cohort studies (iNET-CKD), offers a best-practice guide for researchers developing or improving chronic kidney disease (CKD) cohorts.   Read “The design and conduct of cohort studies of peoples with CKD – international perspectives from iNET-CKD”    The paper outlines key considerations for developing...

From ISN Fellowship to specialist glomerular disease care in Malaysia 

  Dr. Chan performs an enzyme-linked immunosorbent assay in the Mayer IgA Nephropathy Laboratory at the University of Leicester   “The fellowship provides far more than clinical knowledge”  When Chee Eng Chan applied for an ISN Fellowship, his goal was to build the clinical expertise and confidence needed to improve care for patients with complex glomerular diseases in his home country, Malaysia.   During...

Bring your research to the global kidney care stage 

WCN’27 welcomes your abstract submission.  Whether your work focuses on clinical care, research, education, implementation, or health systems, WCN offers an opportunity to share your findings with the global kidney care community. Get ready to submit your abstract!  Need help shaping your abstract? Start with these ISN resources:  Explore the top 5 reasons to submit an...

Call for applications: Kidney International Reports® editor-in-chief  

The ISN invites applications for editor-in-chief (EIC) of Kidney International Reports®.   The EIC will shape the journal’s editorial direction and support the publication of high-quality, clinically relevant kidney research for a global audience. Applications close on July 31, 2026.   View the role, criteria, and how to apply 

ISN global engagement: supporting kidney care in Malaysia  

In July, the ISN will continue its support of kidney care advancement in the region with its participation in the MSN Congress.   Malaysian Society of Nephrology Congress (MSN 2026)   July 24-26, 2026                 Kuala Lumpur, Malaysia    The MSN 2026 congress will be followed by a 2-day ISN Scientific Writing Course (SWC) from July 27-28, delivered by the ISN and MSN.   Several members of the ISN SWC faculty will present talks at the MSN...

ISN Journal summaries on vitamin D for minimal change disease and AKI caused by West Nile virus  

Kidney International®   A randomized controlled non-inferiority trial examined lower dose prednisolone and activated vitamin D in adult minimal change podocytopathy  This study tested whether lower-dose prednisolone combined with activated vitamin D could match standard high-dose prednisolone for remission in adults with minimal change disease while reducing steroid toxicity.   Although non-inferiority was not formally established, the lower-dose regimen...

Feng Qian to receive the 2027 Lillian Jean Kaplan International Prize for PKD 

“I look forward to continuing the pursuit of discoveries that deepen our understanding of PKD and ultimately improve the lives of patients and families affected by this disease.”  Please join the ISN in congratulating Feng Qian, winner of the 2027 Lillian Jean Kaplan International Prize for Advancement in the Understanding of Polycystic Kidney Disease (PKD).  Dr. Qian* is an...

Play your part in turning the WHO kidney health resolution into action 

Advocating for national kidney health action just got easier. The ISN has developed a one-page tool for advocating with government and health system stakeholders showing how they can support the national implementation of the WHO kidney health resolution.   Download and share the one-pager   Based on an ISN-led policy paper published in The Lancet in May 2026, the one-pager outlines five practical steps countries can take to move from commitment to implementation,...

Bringing global expertise to local nephrology education in Bangladesh, the Philippines, Botswana, and Côte d’Ivoire

The ISN Continuing Medical Education (CME) Program continues to support regional and national nephrology meetings that respond to local educational needs. From hands-on workshops to specialist-led sessions, these events have strengthened practical skills, shared expertise, and built kidney care capacity across diverse settings. Delegates at the “Pediatric Dialysis: Ins & Outs” workshop in Bangladesh, supported...

ISN Journal summaries on conventional cytotoxic chemotherapy and Taiwan’s living kidney donation policy 

Kidney International®   Conventional cytotoxic chemotherapy–associated nephrotoxicity: consensus report of the 34th Acute Disease Quality Initiative (ADQI) Workgroup  Conventional cytotoxic chemotherapy remains essential in cancer care, but can cause acute and chronic kidney injury.   The 34th ADQI Workgroup reviewed the epidemiology, mechanisms, risk factors, clinical manifestations, prevention, and management of nephrotoxicity linked to commonly used agents.   The resulting consensus report emphasizes clinician awareness,...